6-Formylindolo[3,2-b]carbazole (FICZ) Enhances The Expression of Tumor Suppressor miRNAs, miR-22, miR-515-5p, and miR-124-3p in MCF-7 Cells
Mobini, Banakar, Tamaddon et al
Cell J (2020) 22, 115-120
Alteration of Cytoskeleton Morphology and Gene Expression in Human Breast Cancer Cells under Simulated Microgravity
Strube, Infanger, Wehland et al
Cell J (2020) 22, 106-114
Phospholipase-Cγ1 Signaling Protein Down-Regulation by Oligoclonal-VHHs based Immuno-Liposome: A Potent Metastasis Deterrent in HER2 Positive Breast Cancer Cells
Asadpour, Rahbarizadeh
Cell J (2020) 22, 30-39
Microtomographic characterization of calcifications in canine mammary tumours
Reis, Oliveira, Pereira et al
Vet Comp Oncol (2019)
Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer
Rodrigues-Ferreira, Molina, Nahmias
Breast Cancer Res. Treat. (2019)
Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials
Qian, Li, Ruan et al
Breast Cancer Res. Treat. (2019)
LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells
Hirano, Takada, Furukawa
Histochem. Cell Biol. (2019)
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside
Abdel-Aziz, Saadeldin, D'Amico et al
Eur. J. Cancer (2019) 122, 22-41
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme
Davidson, Aronson, Howard-Reeves et al
Eur. J. Cancer (2019) 122, 12-21
Picroside II, an iridoid glycoside from Picrorhiza kurroa, suppresses tumor migration, invasion, and angiogenesis in vitro and in vivo
Lou, Zhu, Xu et al
Biomed. Pharmacother. (2019) 120, 109494
Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial
Golshan, Wong, Loibl et al
Eur J Surg Oncol (2019)
Dosimetric evaluation of the INTRABEAM system for breast intraoperative radiotherapy: A single-institution experience
Shaikh, Nalichowski, Joiner et al
Med Dosim (2019)
Making an informed choice: Which breast reconstruction type has the lowest complication rate?
Hangge, Jogerst, Mohsen et al
Am. J. Surg. (2019)

Vialon, Desailloud, Caron
Ann. Endocrinol. (Paris) (2019) 80 Suppl 1, S19-S28
Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells
Sinha, Perera, Cannon
Biomed. Pharmacother. (2019) 120, 109468
Metabolic profiling of seminal plasma from teratozoospermia patients
Mehrparvar, Chashmniam, Nobakht et al
J Pharm Biomed Anal (2019) 178, 112903
Cancer screening in adults with down syndrome, a proposal
Rethoré, Rouëssé, Satgé
Eur J Med Genet (2019)
Combined NK cell therapy and radiotherapy exhibit long-term therapeutic and anti-metastatic effects in a human triple negative breast cancer model
Kim, Jeong, Lee et al
Int. J. Radiat. Oncol. Biol. Phys. (2019)
MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression
Menbari, Rahimi, Ahmadi et al
Life Sci. (2019)
Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway
Zhang, Huang, Zhao
Arch. Biochem. Biophys. (2019)